Skip to main content
Log in

Pharmacokinetics of tiaprofenic acid in normal rabbits and rabbits subjected to joint immobilisation

  • Inflammation
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

In a previous study, tiaprofenic acid (TA) was administered daily over a 30-day period at 5 and 10 mg/kg of body weight subcutaneously (s.c.) to animals with arthritis induced by immobilisation. The 10 mg/kg dose exacerbated the loss of proteoglycan from joint cartilage but the 5 mg/kg dose showed protective effects on articular cartilage. These results led us to investigate the concentration of TA achieved in synovial fluid of both the immobilised and non-immobilised rabbit joints after single s.c doses of 5 or 10 mg/kg. The halflives of elimination of TA from the synovial fluids of the immobilised joints were 1.27 and 1.07 h after the 5 and 10 mg doses, respectively, and 0.66 and 0.39 h in the non-immobilised contralateral joints. Clearances from synovial fluid to plasma were found to be 0.41 and 0.55 ml/h/kg from the immobilised joints after the 5 and 10 mg doses, respectively, and 0.11 and 0.25 ml/h/kg from the non-immobilised contralateral joints. The peak concentration of TA achieved in synovial fluid of immobilised knee joints after a single s.c. injection of 10 mg/kg was approximately two times greater than the concentrations achieved after administration of 5 mg/kg by the same route and two to six times greater than the levels achieved after oral administration of TA at 600 mg/day in humans.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. G. Katona and R. Burgos-Vargas,Clinical experience with intramuscular injection of tiaprofenic acid in rheumatic diseases, with particular emphasis on time of onset and duration of the analgesic effects. Drugs35 (Suppl. 1), 72–80 (1988).

    Google Scholar 

  2. H. E. van der Aa,A comparative trial of the analgesic effect of tiaprofenic acid and indomethacin in post-operative pain following spinal surgery in patients with radicular syndrome. Pharmatherapeutica4, 43–47 (1984).

    Google Scholar 

  3. R. Deraedt, J. Benzoni and F. Delevallee,Pharmacological profile of tiaprofenic acid. Rheumatology7, 70–77 (1982).

    Google Scholar 

  4. T. J. Daymond and F. J. Rowell,Reduction of prostaglandin E2 concentrations in synovial fluid of patients suffering from rheumatoid arthritis following tiaprofenic or indomethacin treatment. Drugs35 (Suppl. 1) 4–8 (1988).

    Google Scholar 

  5. A. Maccagno, O. Sebastian and E. Di Georgio,Comparative double-blind study of tiaprofenic acid versus piroxicam in the treatment of osteoarthritis of the knee. Drugs35 (Suppl. 1), 64–67 (1988).

    Google Scholar 

  6. S. Tanaka,Clinical evaluation of tiaprofenic acid in the treatment of osteoarthritis. Focus Tiaprofenic Acid New Trends Rheumatol.5, 169–179 (1987).

    Google Scholar 

  7. I. Meyer-Carrive and P. Ghosh,Effects of tiaprofenic acid (Surgam) on cartilage proteoglycans in the rabbit joint immobilisation model. Ann. Rheum. Dis.51, 448–455 (1992).

    Google Scholar 

  8. T. A. Baillie, W. G. Adams, E. T. Kaiser, L. S. Olanoff, G. W. Halstead, H. Harpootlian and J. G. van Giessen,Mechanistic studies of the metabolic chiral inversion of (R)-ibuprofen in humans. J. Pharmacol. Exp. Ther.249, 517–523 (1989).

    Google Scholar 

  9. N. N. Singh, F. Jamali, F. M. Pasuto, A. S. Russel, R. T. Coutts and K. S. Drader,Pharmacokinetics of the enantiomers of tiaprofenic acid in humans. J. Pharm. Sci.75, 439–442 (1986).

    Google Scholar 

  10. R. O. Day, K. M. Williams, G. G. Graham, E. J. Lee, R. D. Knihicki and G. D. Champion,Stereoselective disposition of ibuprofen enantiomers in synovial fluid. Clin. Pharmacol. Ther.43, 480–487 (1988).

    Google Scholar 

  11. A. Langenkiöld, J.-E. Michelsson and T. Videman,Osteoarthritis of the knee in the rabbit produced by immobilisation. Acta Orthop. Scand.50, 1–14 (1979).

    Google Scholar 

  12. R. H. Pearce and M. H. Mathieson,Quantitative isolation of purified acidic glycosaminoglycans from rat skin. Can. J. Biochem.45, 1565–1576 (1976).

    Google Scholar 

  13. J. Mandel, The Statistical Analysis of Experimental Data, Interscience, New York 1964.

    Google Scholar 

  14. W. A. Coburn,Simultaneous pharmacokinetic and pharmacodynamic modelling. J. Pharmacokin. Biopharm.9, 367–388 (1981).

    Google Scholar 

  15. D. A. Noe and K. M. Kumor,Drug kinetics in low flux (small) anatomic compartments. J. Pharm. Sci.72, 718–719 (1983).

    Google Scholar 

  16. J. Pottier, D. Berlin and J. P. Raynaud.,Pharmacokinetics of the anti-inflammatory tiaprofenic acid in humans, mice, rats, rabbits and dogs. J. Pharm. Sci.66, 1030–1036 (1977).

    Google Scholar 

  17. G. G. Graham,Kinetics of non-steroidal anti-inflammatory drugs in synovial fluid. Agents and Actions24 (Suppl.), 66–75 (1988).

    Google Scholar 

  18. W. J. Wallis and P. A. Simkin,Antirheumatic drug concentrations in human synovial fluid and synovial tissue: Observations on extravascular pharmacokinetics. Clin. Pharmacokinet.8, 496–522 (1983).

    Google Scholar 

  19. T. J. Daymond and R. Herbert,Simultaneous bioavailability of tiaprofenic acid (Surgam) in serum and synovial fluid in patients with rheumatoid arthritis. Rheumatology7, 88–193 (1982).

    Google Scholar 

  20. S. Ahlstrom, P. Gedda and H. Herdberg,Disappearance of radioactive albumin from joints in rheumatoid arthritis. Acta Rheumatol. Scand. 2, 129–136 (1956).

    Google Scholar 

  21. P. Simkin,Synovial Physiology; Arthritis and Allied Conditions (Ed. D. J. McCarty) pp. 167–178 Lea & Febiger, Philadelphia, PA 1979.

    Google Scholar 

  22. F. Jamali, A. S. Russel, C. Lehman and B. W. Berry,Pharmacokinetics of tiaprofenic acid in healthy and arthritic subjects. J. Pharm. Sci.74, 954–956 (1985).

    Google Scholar 

  23. O. G. Nielsen, A. Storhaug and O. Dale,Binding of tiaprofenic acid to human sera and isolated serum proteins. Arzneim.-Forsch.35(I), 984–987 (1985).

    Google Scholar 

  24. K. D. Rainsford, A. Schweitzer and K. Brune,Autoradiographic and biochemical observations on the distribution of non-steroidal anti-inflammatory drugs. Arch. Int. Pharmacodyn.250, 180–194 (1981).

    Google Scholar 

  25. E. Vignon, P. Mathieu, N. Croupie, H. Cloppet, D. Herbage, P. Louisot and M. Richard,Effects of tiaprofenic acid on interleukin I, phospholipase A 2 activity, prostaglandins, neutral protease, and collagenase activity in rheumatoid synovial fluid. Semin. Arthritis Rheum.18 (Suppl. 1), 11–15 (1989).

    Google Scholar 

  26. C. Iride, D. Guidi, A. M. Cerbone, F. Cirillo, G. Di Santo, A. Piatto, M. Pannain, P. L. Mattiolli and G. Di Minno,The effects of tiaprofenic acid on the synthesis of plasma and renal prostaglandins in normal subjects. Focus Tiaprofenic Acid New Trends Rheumatol.5, 156–168 (1987).

    Google Scholar 

  27. J. Dingle and M. Shield,Misoprostol reverses adverse effects of interleukin-1 and NSAIDs on cartilage in organ culture. Arthritis Rheum.33, S52 (1990).

    Google Scholar 

  28. H. M. van Beuningen, O. J. Arntz and W. B. van den Berg,In vivo effects of interleukin-1 on articular cartilage. Arthritis Rheum.34, 606–615 (1991).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meyer-Carrive, I., Graham, G.G. & Ghosh, P. Pharmacokinetics of tiaprofenic acid in normal rabbits and rabbits subjected to joint immobilisation. Agents and Actions 39, 59–68 (1993). https://doi.org/10.1007/BF01975715

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01975715

Keywords

Navigation